Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("P Glycoprotein")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4115

  • Page / 165
Export

Selection :

  • and

P-glycoprotein function in the elderlyBRENNER, Stefanie S; KLOTZ, Ulrich.European journal of clinical pharmacology. 2004, Vol 60, Num 2, pp 97-102, issn 0031-6970, 6 p.Article

Thalidomide does not interact with P-glycoproteinZIMMERMANN, Christian; GUTMANN, Heike; DREWE, Juergen et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 599-606, issn 0344-5704, 8 p.Article

Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activitiesMORITA, Naomi; YASUMORI, Toshio; NAKAYAMA, Kazuo et al.Biochemical pharmacology. 2003, Vol 65, Num 11, pp 1843-1852, issn 0006-2952, 10 p.Article

Effect of clarithromycin on steady-state digoxin concentrationsTANAKA, Hideko; MATSUMOTO, Kana; UENO, Kazuyuki et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 178-181, issn 1060-0280, 4 p.Article

Evaluation of inhibitory potencies for compounds inhibiting p-glycoprotein but without maximum effects : F2 valuesWEISS, Johanna; HAEFELI, Walter Emil.Drug metabolism and disposition. 2006, Vol 34, Num 2, pp 203-207, issn 0090-9556, 5 p.Article

Improved oral delivery of paclitaxel following administration in nanoemulsion formulationsTIWARI, Sandip B; AMIJI, Mansoor M.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 3215-3221, issn 1533-4880, 7 p.Article

Evidence of P-glycoprotein sequence diversity in cyathostominsDROGEMULLER, Michaela; SCHNIEDER, T; VON SAMSON-HIMMELSTIERNA, G et al.The Journal of parasitology. 2004, Vol 90, Num 5, pp 998-1003, issn 0022-3395, 6 p.Article

Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetateCHENG WANG; ZHANG, Jin-Xia; SHEN, Xiao-Ling et al.Biochemical pharmacology. 2004, Vol 68, Num 5, pp 843-855, issn 0006-2952, 13 p.Article

Suppressive effect of tobacco smoke extracts on oral P-glycoprotein function and its impact in smoke-induced insult to oral epidermal cellsPAN, Wen-Chi; CHEN, Ruei-Ming; SHEN, Yuh-Chiang et al.Toxicology letters. 2009, Vol 185, Num 2, pp 116-123, issn 0378-4274, 8 p.Article

Drug efficact and drug resistance : Drug efficact and drug resistanceFENG QIAN; DONGZHI WEI; QIANG ZHANG et al.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 3, pp 64-69, issn 0753-3322, 6 p.Article

A topological substructural approach for the prediction of P-glycoprotein substratesCABRERA, Miguel Angel; GONZALEZ, Isabel; FERNANDEZ, Carlos et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 3, pp 589-606, issn 0022-3549, 18 p.Article

Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activityMORIGUCHI, Jun; KATO, Ryuji; NAKAGAWA, Machiko et al.European journal of pharmacology. 2007, Vol 565, Num 1-3, pp 220-224, issn 0014-2999, 5 p.Article

Repetitive doxorubicin treatment of glioblastoma enhances the PGP expression: a special role for endothelial cellsRITTIERODT, Marion; HARADA, Kunyu.Experimental and toxicologic pathology (Print). 2003, Vol 55, Num 1, pp 39-44, issn 0940-2993, 6 p.Article

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's diseaseDROZDZIK, Marek; BIALECKA, Monika; MYSLIWIEC, Katarzyna et al.Pharmacogenetics (London). 2003, Vol 13, Num 5, pp 259-263, issn 0960-314X, 5 p.Article

A phase i and pharmacokinetic study of BAY59: A novel taxaneRAMNATH, N; HAMM, J; SCHWARTZ, G et al.Oncology. 2004, Vol 67, Num 2, pp 123-129, issn 0030-2414, 7 p.Article

Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patientsCHIAMPANICHAYAKUL, Sawitree; ANUCHAPREEDA, Songyot; CHRUEWKAMLOW, Nuttapol et al.International journal of hematology. 2010, Vol 92, Num 2, pp 326-333, issn 0925-5710, 8 p.Article

Effect of indinavir on the intestinal exsorption of amprenavir, saquinavir and nelfinavir after intravenous administration in ratsGAO, Weihua; KAGEYAMA, Michiharu; TAKADA, Kanji et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 2, pp 199-204, issn 0918-6158, 6 p.Article

Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interactionSIPE, Brooke E; JONES, Ronald J; BOKHART, Gordon H et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 808-811, issn 1060-0280, 4 p.Article

Effects of reactive oxygen species on cell proliferation and death in HeLa cells and its MDR1-overexpressing derivative cell lineLIU, Yu-Wen; SAKAEDA, Toshiyuki; TAKARA, Kohji et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 2, pp 278-281, issn 0918-6158, 4 p.Article

The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis studyTSAI, T. H; LIU, S. C; TSAI, P. L et al.British journal of pharmacology. 2002, Vol 137, Num 8, pp 1314-1320, issn 0007-1188, 7 p.Article

Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoproteinKEOGH, John P; KUNTA, Jeevan R.European journal of pharmaceutical sciences. 2006, Vol 27, Num 5, pp 543-554, issn 0928-0987, 12 p.Article

Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cellsTAKARA, Kohji; TSUJIMOTO, Masayuki; KOKUFU, Misato et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 2, pp 205-209, issn 0918-6158, 5 p.Article

Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substratesMOADDEL, Ruin; BULLOCK, Peter L; WAINER, Irving W et al.Journal of chromatography. B. 2004, Vol 799, Num 2, pp 255-263, issn 1570-0232, 9 p.Article

Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforinWANG, Er-Jia; BARECKI-ROACH, Mary; JOHNSON, William W et al.Journal of pharmacy and pharmacology. 2004, Vol 56, Num 1, pp 123-128, issn 0022-3573, 6 p.Article

Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein effluxSHAN, Yong-Qiang; GANG REN; JIANG, Jian-Dong et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 3, pp 446-456, issn 0026-0495, 11 p.Article

  • Page / 165